ArticleBMJ open2025
Clinical and cardiovascular magnetic resonance factors associated with elevated neutrophil-to-lymphocyte ratio in patients with heart failure: an analysis of a single-centre, prospective registry.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe neutrophil-to-lymphocyte ratio (NLR) is defined as the ratio of neutrophils to lymphocytes measured in the full blood count. It has been studied across a range of conditions including cancer, sepsis and stroke. It has been proven that in patients with heart failure (HF) with reduced ejection fraction (HF-rEF), an elevated NLR reflects a higher risk of adverse outcomes. The aim of this study is to identify which clinical or cardiovascular magnetic resonance (CMR) factors are associated with an elevated NLR in patients with HF-rEF.
designThis study was an analysis of the MATCH registry (MyocArdial Tissue Characteristics in patients with heart failure according to glycaemic status), a prospectively recruited registry of patients presenting with a new diagnosis of HF and referred to our centre for a CMR.
settingSingle-centre study performed in the Advanced Imaging Centre, Leeds General Infirmary, UK. Data collection took place between February 2018 and March 2023.
participantsPatients (N=605) with newly diagnosed HF-rEF referred for CMR.
interventionParticipants underwent clinical assessment, medication review, full blood count and CMR on the same day. The CMR protocol included quantitative assessment of myocardial blood flow at stress and rest, late gadolinium enhancement imaging and parametric mapping. Association between NLR, clinical and CMR parameters was examined by linear regression.
resultsThe factors which were found to be significantly associated with an elevated NLR were age, atrial fibrillation, N-terminal pro-B-type natriuretic peptide (NT-proBNP), presence of ischaemic fibrosis and myocardial perfusion reserve (MPR). There was no association between NLR and CMR markers of inflammation (native T1 and T2). On multiple regression after correction for age, atrial fibrillation, New York Heart Association classification and left ventricular ejection fraction, the association between NLR and presence of ischaemic fibrosis (coefficient 0.68, 95% CI 0.23 to 1.12, p=0.003) and NT-proBNP (coefficient 0.0002, 95% CI 0.00006 to 0.0003, p=0.002) remained significant. However, the association between MPR was no longer significant (coefficient -0.09, 95% CI -0.28 to 0.09, p=0.330).
conclusionIn patients with HF with elevated NLR, these findings show an association with worsening congestion (NT-proBNP) and occult coronary artery disease (ischaemic fibrosis). Further studies are required to demonstrate if this accounts for the adverse prognosis. Importantly, there was no association between myocardial inflammation or oedema and NLR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.